Wang Y, Hu Y, Ma Y, Li P, et al. RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine. Vaccine 2023 Nov 27:S0264-410X(23)01381-6. doi: 10.1016/j.vaccine.2023.
PMID: 38016845